avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
En1
|
ENSMUSG00000058665.7 | engrailed 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
En1 | mm10_v2_chr1_+_120602405_120602418 | 0.11 | 5.3e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
3.0 | 9.0 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
1.8 | 9.0 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.6 | 6.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.3 | 3.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.1 | 3.4 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.9 | 2.6 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.8 | 2.4 | GO:0048007 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 3.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 2.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.7 | 2.7 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.6 | 2.3 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.6 | 1.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.5 | 2.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 4.9 | GO:1900194 | receptor guanylyl cyclase signaling pathway(GO:0007168) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.4 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.4 | 3.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 2.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 4.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 2.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 1.1 | GO:0006507 | GPI anchor release(GO:0006507) |
0.4 | 1.8 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 2.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 1.0 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.3 | 1.0 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 1.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 1.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 1.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 1.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 1.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 1.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.0 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.3 | 1.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 3.6 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.7 | GO:0030862 | neuroblast division in subventricular zone(GO:0021849) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.2 | 2.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.7 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.2 | 1.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) |
0.2 | 1.8 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.4 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.6 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.2 | 2.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 1.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.8 | GO:1902956 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.2 | 6.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 5.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 2.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 1.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 2.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 3.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 1.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 1.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.5 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.6 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 2.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.8 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 3.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.2 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 2.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 3.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 2.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.4 | GO:0036395 | pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) negative regulation of pancreatic amylase secretion(GO:1902277) |
0.1 | 0.1 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.9 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.9 | GO:0097647 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 1.6 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.3 | GO:1990167 | protein K6-linked deubiquitination(GO:0044313) protein K27-linked deubiquitination(GO:1990167) |
0.1 | 1.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.4 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.1 | 1.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 1.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.7 | GO:0021539 | subthalamus development(GO:0021539) |
0.1 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.3 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.1 | 1.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 2.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 5.8 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.5 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.4 | GO:0021917 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.1 | 0.9 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 2.2 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 1.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 1.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:1903416 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) response to glycoside(GO:1903416) |
0.1 | 1.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 2.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.1 | 2.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 1.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.3 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.1 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 2.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 4.4 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 1.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 1.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 1.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.0 | 0.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 4.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.8 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 3.1 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 2.6 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.3 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 3.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.5 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.8 | 2.5 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.8 | 9.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 1.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 3.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 5.4 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 2.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 2.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 3.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 4.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 2.4 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 4.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 3.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 3.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 9.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 2.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:1990131 | Iml1 complex(GO:1990130) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 3.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 3.1 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 1.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 4.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 1.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 1.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 2.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 1.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 3.4 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 3.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 4.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.1 | 6.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 4.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.0 | 3.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.0 | 4.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 3.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.7 | 2.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) metallodipeptidase activity(GO:0070573) |
0.6 | 5.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 4.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.5 | 2.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.4 | 2.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 2.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 1.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 14.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.4 | 11.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 1.8 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 3.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 1.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 1.3 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.3 | 6.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 1.8 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.7 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 1.0 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.2 | 2.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 3.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 2.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 0.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.6 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 4.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.6 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.1 | 2.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 2.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 1.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 2.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 1.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 2.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 2.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 7.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 5.3 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 1.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 5.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 1.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 1.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 2.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 5.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 1.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 4.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 3.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 2.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 4.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 1.1 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 3.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 4.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 2.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 7.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 10.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 11.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 13.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 7.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 3.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 3.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 2.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 4.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |